Signaturefd, LLC Axsome Therapeutics, Inc. Transaction History

Signaturefd, LLC

$4.72 Billion
Q1 2024

A detailed history of Signaturefd, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 313 shares of AXSM stock, worth $25,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares

313

Previous 73 328.77%

Holding current value

$25,105

Previous $5,000 380.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$69.39 - $97.64 $16,653 - $23,433	240 Added 328.77%	313 $24,000
Q4 2023 Jan 31, 2024	SELL	$57.42 - $83.61 $3,674 - $5,351	-64 Reduced 46.72%	73 $5,000
Q3 2023 Nov 03, 2023	BUY	$69.25 - $82.21 $4,432 - $5,261	64 Added 87.67%	137 $9,000
Q2 2023 Aug 01, 2023	SELL	$58.41 - $90.35 $1,168 - $1,807	-20 Reduced 21.51%	73 $5,000
Q1 2023 Apr 28, 2023	SELL	$58.39 - $75.0 $37,019 - $47,550	-634 Reduced 87.21%	93 $5,000

Q4 2022 Jan 27, 2023	BUY	$39.94 - $79.72 $25,042 - $49,984	627 Added 627.0%	727 $56,000
Q2 2022 Aug 10, 2022	SELL	$21.74 - $46.75 $586 - $1,262	-27 Reduced 21.26%	100 $4,000
Q1 2022 May 02, 2022	SELL	$23.7 - $41.39 $10,688 - $18,666	-451 Reduced 78.03%	127 $5,000
Q4 2021 Jan 25, 2022	BUY	$30.7 - $43.36 $9,824 - $13,875	320 Added 124.03%	578 $22,000
Q3 2021 Oct 28, 2021	BUY	$19.91 - $68.26 $3,305 - $11,331	166 Added 180.43%	258 $9,000
Q2 2021 Jul 26, 2021	BUY	$50.63 - $73.5 $759 - $1,102	15 Added 19.48%	92 $6,000
Q1 2021 Apr 30, 2021	BUY	$55.91 - $81.44 $3,466 - $5,049	62 Added 413.33%	77 $4,000
Q4 2020 Feb 11, 2021	BUY	$66.31 - $86.52 $132 - $173	2 Added 15.38%	15 $1,000
Q3 2020 Nov 03, 2020	BUY	$68.34 - $85.84 $888 - $1,115	13 New	13 $1,000

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account